The Knobbe Martens summer program is booked with events that foster professional advancement, but that doesn't mean we don't find time for some fun in the sun! #KnobbeMartens #Knobbe #IPLaw #SummerAtKnobbe

Knobbe Martens is pleased to accept applications for the firm’s 2024 2L Diversity Scholarship Program, open to second-year law students belonging to groups historically underrepresented in the legal profession. To learn more, visit: knobbe.com/careers/law-st… #LawStudents #Diversity

Partner Jonathan Menkes discussed the challenges of clearing, protecting and enforcing single letter trademarks with Bloomberg Law in the article "Musk’s Twitter Rebrand Invites ‘X’ Trademark Fallout: Explained.” Read more here: knobbe.com/news/bloomberg…

Knobbe Martens partner Susan Natland shared her thoughts on the most significant trademark decisions so far this year with Law360 in the article “The Biggest Trademark Decisions Of 2023: A Midyear Report”. Read more here: knobbe.com/news/susan-nat…

“FDA Updates Medical Device Shortages List.” Read our latest Medical Device Blog post by Arash Pia here: knobbe.com/blog/fda-updat… #KnobbeMartens #Knobbe #IPLaw #MedicalDevice

FDA Updates Medical Device Shortages List jdsupra.com/legalnews/fda-…

We were pleased to sponsor The LGBTQ+ Bar’s #LavLaw23 Conference and Career Fair in Chicago last week, where attorneys Bita Kianian, Sara Witty, and Nefi Oliva were able to meet with prospective law students and talk with them about a career in IP law at Knobbe Martens.

Knobbe Martens is pleased to announce that it has once again been ranked among the top five most diverse midsize law firms in Law360’s annual Diversity Snapshot. Read more here: knobbe.com/news/knobbe-ma… #KnobbeMartens #Knobbe #IPLaw #Diversity

FDA Releases Draft Guidance for Studies of Medical Devices for Opioid Use Disorder jdsupra.com/legalnews/fda-…

“FDA Releases Draft Guidance for Studies of Medical Devices for Opioid Use Disorder.” Read our latest Medical Device Blog post by Josh Loader here: knobbe.com/blog/fda-relea… #KnobbeMartens #Knobbe #IPLaw #MedicalDevice

We’ve had a great summer at Knobbe Martens filled with exciting and educational events. To wrap up the 2023 program, the summer associates watched the new Barbie movie, enjoyed a hike in Laguna Beach, and spent an evening making Spanish tapas! Until next summer! #SummerAtKnobbe

Knobbe Martens partner Joseph Re shared his thoughts on the current state of litigation funding disclosures with Managing IP in the article “Disclosure debates: firms and funders discuss transparency merits.” Read more here: knobbe.com/news/managing-… #KnobbeMartens #Knobbe #IPLaw

Knobbe Martens is delighted to sponsor the Orange County Bar Association Charitable Fund’s Annual Benefit “Raise Your Glass” in Newport Beach on August 17. Learn more and register here: ocbacf.org #KnobbeMartens #Knobbe #IPLaw

In a recent Cannabis Regulator article, partners Jonathan Hyman and Jonathan Menkes discussed the FTC’s and FDA’s efforts to crack down on the use of deceptive packaging by cannabis companies that may mimic the look of well-known snack brands. Read here: knobbe.com/news/cannabis-…

Mauricio Uribe authored “Coming to Terms (of Service) with your Organization’s Data” where Mr. Uribe discusses Zoom’s updated terms of service. Read it here: knobbe.com/news/coming-te…

FDA Statements and Patent Disclosures jdsupra.com/legalnews/fda-…

Federal Circuit Review | July 2023 jdsupra.com/legalnews/fede…

IPR Petitioners Must Be Permitted to Respond to Claim Constructions First Proposed in Patent Owner Response jdsupra.com/legalnews/ipr-…

Navigating the Regulatory Landscape: FDA Approval and Patent Protection for Software as a Medical Device jdsupra.com/legalnews/navi…